Individualized treatment with pegylated interferon-α for chronic hepatitis B

Antiviral therapy is the basic treatment of chronic hepatitis B, and pegylated interferon-α is one of the first-line treatment drugs. At present, several consensuses have been reached on individualized treatment with pegylated interferon-α, which is playing an important role in clinical practice. Ne...

Full description

Bibliographic Details
Main Author:	WAN Mobin
Format:	Article
Language:	zho
Published:	Editorial Department of Journal of Clinical Hepatology 2018-05-01
Series:	Linchuang Gandanbing Zazhi
Subjects:	hepatitis B chronic interferon-alpha therapy
Online Access:	http://www.lcgdbzz.org/qk_content.asp?id=8958

id	doaj-0a9824e503784897b7919f08511ae923
record_format	Article
spelling	doaj-0a9824e503784897b7919f08511ae9232020-11-24T23:25:24ZzhoEditorial Department of Journal of Clinical HepatologyLinchuang Gandanbing Zazhi1001-52561001-52562018-05-0134593093310.3969/j.issn.1001-5256.2018.05.004Individualized treatment with pegylated interferon-α for chronic hepatitis BWAN Mobin0Department of Infectious Diseases, Changhai Hospital of ShanghaiAntiviral therapy is the basic treatment of chronic hepatitis B, and pegylated interferon-α is one of the first-line treatment drugs. At present, several consensuses have been reached on individualized treatment with pegylated interferon-α, which is playing an important role in clinical practice. New clinical demands appear along with the clinical application of pegylated interferon-α. With reference to relevant literature and personal clinical experience, this article elaborates on some knowledge of individualized treatment with pegylated interferon-α for chronic hepatitis B. http://www.lcgdbzz.org/qk_content.asp?id=8958hepatitis Bchronicinterferon-alphatherapy
collection	DOAJ
language	zho
format	Article
sources	DOAJ
author	WAN Mobin
spellingShingle	WAN Mobin Individualized treatment with pegylated interferon-α for chronic hepatitis B Linchuang Gandanbing Zazhi hepatitis B chronic interferon-alpha therapy
author_facet	WAN Mobin
author_sort	WAN Mobin
title	Individualized treatment with pegylated interferon-α for chronic hepatitis B
title_short	Individualized treatment with pegylated interferon-α for chronic hepatitis B
title_full	Individualized treatment with pegylated interferon-α for chronic hepatitis B
title_fullStr	Individualized treatment with pegylated interferon-α for chronic hepatitis B
title_full_unstemmed	Individualized treatment with pegylated interferon-α for chronic hepatitis B
title_sort	individualized treatment with pegylated interferon-α for chronic hepatitis b
publisher	Editorial Department of Journal of Clinical Hepatology
series	Linchuang Gandanbing Zazhi
issn	1001-5256 1001-5256
publishDate	2018-05-01
description	Antiviral therapy is the basic treatment of chronic hepatitis B, and pegylated interferon-α is one of the first-line treatment drugs. At present, several consensuses have been reached on individualized treatment with pegylated interferon-α, which is playing an important role in clinical practice. New clinical demands appear along with the clinical application of pegylated interferon-α. With reference to relevant literature and personal clinical experience, this article elaborates on some knowledge of individualized treatment with pegylated interferon-α for chronic hepatitis B.
topic	hepatitis B chronic interferon-alpha therapy
url	http://www.lcgdbzz.org/qk_content.asp?id=8958
work_keys_str_mv	AT wanmobin individualizedtreatmentwithpegylatedinterferonaforchronichepatitisb
_version_	1725557773801881600

Individualized treatment with pegylated interferon-α for chronic hepatitis B

Similar Items